BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND HRAS, K-ras, 3265, ENSG00000174775, HRAS1, RASH1, c-bas/has, P01112, N-ras AND Prognosis
14 results:

  • 1. Clinicopathological Features and prognosis of Lung Adenocarcinoma Patients With k-ras Gene Mutation.
    Sun D; Liu Y; Li P; Yang P; Yu G
    Appl Immunohistochem Mol Morphol; 2023 Jul; 31(6):406-413. PubMed ID: 37338109
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. KRAS Exon 3 and PTEN Exon 7 Mutations in Small-cell Lung cancer.
    Lei L; Jiang ZM; Li CH; Lu HY
    Curr Med Sci; 2019 Jun; 39(3):379-384. PubMed ID: 31209806
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The antibiotic clofoctol suppresses glioma stem cell proliferation by activating KLF13.
    Hu Y; Zhang M; Tian N; Li D; Wu F; Hu P; Wang Z; Wang L; Hao W; Kang J; Yin B; Zheng Z; Jiang T; Yuan J; Qiang B; Han W; Peng X
    J Clin Invest; 2019 May; 129(8):3072-3085. PubMed ID: 31112526
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. RNA-binding Protein UNR Promotes Glioma Cell Migration and Regulates the Expression of Ribosomal Protein L9.
    Tian NY; Qi YJ; Hu Y; Yin B; Yuan JG; Qiang BQ; Peng XZ; Han W
    Chin Med Sci J; 2018 Sep; 33(3):143-151. PubMed ID: 30266104
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Role of MEK partner-1 in cancer stemness through MEK/ERK pathway in cancerous neural stem cells, expressing EGFRviii.
    Kwon SJ; Kwon OS; Kim KT; Go YH; Yu SI; Lee BH; Miyoshi H; Oh E; Cho SJ; Cha HJ
    Mol Cancer; 2017 Aug; 16(1):140. PubMed ID: 28830458
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Mitochondria-Translocated PGK1 Functions as a Protein Kinase to Coordinate Glycolysis and the TCA Cycle in Tumorigenesis.
    Li X; Jiang Y; Meisenhelder J; Yang W; Hawke DH; Zheng Y; Xia Y; Aldape K; He J; Hunter T; Wang L; Lu Z
    Mol Cell; 2016 Mar; 61(5):705-719. PubMed ID: 26942675
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The contribution of tumor and host tissue factor expression to oncogene-driven gliomagenesis.
    Magnus N; Meehan B; Garnier D; Hashemi M; Montermini L; Lee TH; Milsom C; Pawlinski R; Ohlfest J; Anderson M; Mackman N; Rak J
    Biochem Biophys Res Commun; 2014 Nov; 454(2):262-8. PubMed ID: 25450387
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Addition of MR imaging features and genetic biomarkers strengthens glioblastoma survival prediction in TCGA patients.
    Nicolasjilwan M; Hu Y; Yan C; Meerzaman D; Holder CA; Gutman D; Jain R; Colen R; Rubin DL; Zinn PO; Hwang SN; Raghavan P; Hammoud DA; Scarpace LM; Mikkelsen T; Chen J; Gevaert O; Buetow K; Freymann J; Kirby J; Flanders AE; Wintermark M;
    J Neuroradiol; 2015 Jul; 42(4):212-21. PubMed ID: 24997477
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. MEK targeting in n-ras mutated metastatic melanoma.
    Thumar J; Shahbazian D; Aziz SA; Jilaveanu LB; Kluger HM
    Mol Cancer; 2014 Mar; 13():45. PubMed ID: 24588908
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Activity of pemetrexed and high-dose gefitinib in an EGFR-mutated lung adenocarcinoma with brain and leptomeningeal metastasis after response to gefitinib.
    Yuan Y; Tan C; Li M; Shen H; Fang X; Hu Y; Ma S
    World J Surg Oncol; 2012 Nov; 10():235. PubMed ID: 23134665
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. BMI1 cooperates with H-RAS to induce an aggressive breast cancer phenotype with brain metastases.
    Hoenerhoff MJ; Chu I; Barkan D; Liu ZY; Datta S; Dimri GP; Green JE
    Oncogene; 2009 Aug; 28(34):3022-32. PubMed ID: 19543317
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Biomarkers for the lung cancer diagnosis and their advances in proteomics.
    Sung HJ; Cho JY
    BMB Rep; 2008 Sep; 41(9):615-25. PubMed ID: 18823584
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Analyses of novel prognostic factors in neuroblastoma patients.
    Ootsuka S; Asami S; Sasaki T; Yoshida Y; Nemoto N; Shichino H; Chin M; Mugishima H; Suzuki T
    Biol Pharm Bull; 2007 Dec; 30(12):2294-9. PubMed ID: 18057715
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Signaling from p53 to NF-kappaB determines the chemotherapy responsiveness of neuroblastoma.
    Armstrong MB; Bian X; Liu Y; Subramanian C; Ratanaproeksa AB; Shao F; Yu VC; Kwok RP; Opipari AW; Castle VP
    Neoplasia; 2006 Nov; 8(11):967-77. PubMed ID: 17132229
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.